Clinical Genetic Testing in Epilepsy
Open Access
- 1 July 2015
- journal article
- research article
- Published by SAGE Publications in Epilepsy Currents
- Vol. 15 (4) , 197-201
Abstract
New technologies for mutation detection in the human genome have greatly increased our understanding of epilepsy genetics. Application of genomic technologies in the clinical setting allows for more efficient genetic diagnosis in some patients; therefore, it is important to understand the types of tests available and the types of mutations that can be detected. Making a genetic diagnosis improves overall patient care by enhancing prognosis and recurrence risk counseling and informing treatment decisions.Keywords
This publication has 29 references indexed in Scilit:
- Investigating the genetic basis of fever‐associated syndromic epilepsies using copy number variation analysisEpilepsia, 2015
- Copy number variation plays an important role in clinical epilepsyAnnals of Neurology, 2014
- GRIN2B mutations in west syndrome and intellectual disability with focal epilepsyAnnals of Neurology, 2014
- Copy number variants are frequent in genetic generalized epilepsy with intellectual disabilityNeurology, 2013
- De novo mutations in epileptic encephalopathiesNature, 2013
- GRIN2A mutations cause epilepsy-aphasia spectrum disordersNature Genetics, 2013
- Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1Nature Genetics, 2013
- De Novo Pathogenic SCN8A Mutation Identified by Whole-Genome Sequencing of a Family Quartet Affected by Infantile Epileptic Encephalopathy and SUDEPThe American Journal of Human Genetics, 2012
- A Focal Epilepsy and Intellectual Disability Syndrome Is Due to a Mutation in TBC1D24The American Journal of Human Genetics, 2010
- TBC1D24, an ARF6-Interacting Protein, Is Mutated in Familial Infantile Myoclonic EpilepsyThe American Journal of Human Genetics, 2010